11 March 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on five medicines.

Talazoparib tosylate (Talzenna) was accepted for treating adults with BRCA1 or 2 mutated HER2 negative advanced breast cancer.

Read SMC press release